Immunome, Inc. (IMNM)
NASDAQ·Healthcare·Biotechnology
$18.78
+4.97%
Mkt Cap $2.12B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (16 analysts)
$33.00
Range $24.00 – $37.00
Implied Upside
+75.7%
Consensus $33.00 vs current $18.78
NASDAQ·Healthcare·Biotechnology
$18.78
+4.97%
Mkt Cap $2.12B
Buy
9
Hold
0
Sell
0
Price Target (16 analysts)
$33.00
Range $24.00 – $37.00
+75.7%
Consensus $33.00 vs current $18.78